These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 24269855)

  • 1. Continuous ultrafiltration for congestive heart failure: the CUORE trial.
    Marenzi G; Muratori M; Cosentino ER; Rinaldi ER; Donghi V; Milazzo V; Ferramosca E; Borghi C; Santoro A; Agostoni P
    J Card Fail; 2014 Jan; 20(1):9-17. PubMed ID: 24269855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Continuous ultrafiltration for congestive heart failure: the CUORE trial.
    Marenzi G; Muratori M; Cosentino ER; Rinaldi ER; Donghi V; Milazzo V; Ferramosca E; Borghi C; Santoro A; Agostoni P
    J Card Fail; 2014 May; 20(5):378.e1-9. PubMed ID: 25089313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure.
    Rogers HL; Marshall J; Bock J; Dowling TC; Feller E; Robinson S; Gottlieb SS
    J Card Fail; 2008 Feb; 14(1):1-5. PubMed ID: 18226766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrafiltration is associated with fewer rehospitalizations than continuous diuretic infusion in patients with decompensated heart failure: results from UNLOAD.
    Costanzo MR; Saltzberg MT; Jessup M; Teerlink JR; Sobotka PA;
    J Card Fail; 2010 Apr; 16(4):277-84. PubMed ID: 20350693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. N-terminal pro-B-type natriuretic peptide-guided, intensive patient management in addition to multidisciplinary care in chronic heart failure a 3-arm, prospective, randomized pilot study.
    Berger R; Moertl D; Peter S; Ahmadi R; Huelsmann M; Yamuti S; Wagner B; Pacher R
    J Am Coll Cardiol; 2010 Feb; 55(7):645-53. PubMed ID: 20170790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rationale and design of the Aquapheresis Versus Intravenous Diuretics and Hospitalization for Heart Failure (AVOID-HF) trial.
    Costanzo MR; Negoianu D; Fonarow GC; Jaski BE; Bart BA; Heywood JT; Nabut JL; Schollmeyer MP
    Am Heart J; 2015 Sep; 170(3):471-82. PubMed ID: 26385030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in brain natriuretic peptide levels and bioelectrical impedance measurements after treatment with high-dose furosemide and hypertonic saline solution versus high-dose furosemide alone in refractory congestive heart failure: a double-blind study.
    Paterna S; Di Pasquale P; Parrinello G; Fornaciari E; Di Gaudio F; Fasullo S; Giammanco M; Sarullo FM; Licata G
    J Am Coll Cardiol; 2005 Jun; 45(12):1997-2003. PubMed ID: 15963399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results of intensified, N-terminal-pro-B-type natriuretic peptide-guided versus symptom-guided treatment in elderly patients with heart failure: five-year follow-up from TIME-CHF.
    Sanders-van Wijk S; Maeder MT; Nietlispach F; Rickli H; Estlinbaum W; Erne P; Rickenbacher P; Peter M; Pfisterer MP; Brunner-La Rocca HP;
    Circ Heart Fail; 2014 Jan; 7(1):131-9. PubMed ID: 24352403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrafiltration for the treatment of diuretic-resistant, recurrent, acute decompensated heart failure: experience in a single center.
    De Maria E; Pignatti F; Patrizi G; Benenati PM; Ricci S; Cappelli S
    J Cardiovasc Med (Hagerstown); 2010 Aug; 11(8):599-604. PubMed ID: 20442667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intermittent haemodiafiltration in refractory congestive heart failure: BNP and balance of inflammatory cytokines.
    Libetta C; Sepe V; Zucchi M; Pisacco P; Cosmai L; Meloni F; Campana C; Rampino T; Monti C; Tavazzi L; Dal Canton A
    Nephrol Dial Transplant; 2007 Jul; 22(7):2013-9. PubMed ID: 17298996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrafiltration in heart failure with preserved ejection fraction: comparison with systolic heart failure patients.
    Jefferies JL; Bartone C; Menon S; Egnaczyk GF; O'Brien TM; Chung ES
    Circ Heart Fail; 2013 Jul; 6(4):733-9. PubMed ID: 23735537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
    Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
    Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrafiltration versus intravenous diuretics for patients hospitalized for acute decompensated heart failure.
    Costanzo MR; Guglin ME; Saltzberg MT; Jessup ML; Bart BA; Teerlink JR; Jaski BE; Fang JC; Feller ED; Haas GJ; Anderson AS; Schollmeyer MP; Sobotka PA;
    J Am Coll Cardiol; 2007 Feb; 49(6):675-83. PubMed ID: 17291932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Determination of brain natriuretic peptide levels and its N-terminal fragment for the evaluation of renal replacement therapies efficiency in patients with decompensated chronic heart failure].
    Tabak'ian EA; Zaruba AIu; Rogoza AN; Ataullakhanova DM; Kukharchuk VV
    Ter Arkh; 2010; 82(8):24-9. PubMed ID: 20873241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive impairment in heart failure: results from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF) randomized trial.
    Huijts M; van Oostenbrugge RJ; Duits A; Burkard T; Muzzarelli S; Maeder MT; Schindler R; Pfisterer ME; Brunner-La Rocca HP;
    Eur J Heart Fail; 2013 Jun; 15(6):699-707. PubMed ID: 23384944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain natriuretic peptide and cardiac resynchronization therapy in patients with mildly symptomatic heart failure.
    Brenyo A; Barsheshet A; Rao M; Huang DT; Zareba W; McNitt S; Hall WJ; Peterson DR; Solomon SD; Moss AJ; Goldenberg I
    Circ Heart Fail; 2013 Sep; 6(5):998-1004. PubMed ID: 23801020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and methods of the Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy (PROTECT) Study.
    Bhardwaj A; Rehman SU; Mohammed A; Baggish AL; Moore SA; Januzzi JL
    Am Heart J; 2010 Apr; 159(4):532-538.e1. PubMed ID: 20362709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How often we need to measure brain natriuretic peptide (BNP) blood levels in patients admitted to the hospital for acute severe heart failure? Role of serial measurements to improve short-term prognostic stratification.
    Faggiano P; Valle R; Aspromonte N; D'Aloia A; Di Tano G; Barro S; Giovinazzo P; Milani L; Lorusso R; Dei Cas L
    Int J Cardiol; 2010 Apr; 140(1):88-94. PubMed ID: 19321212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.